Therapeutic efficacy of theophylline in chronic lymphocytic leukemia

被引：0
|
作者：
Della Makower
Ummekalsoom Malik
Yelena Novik
Peter H Wiernik
机构：
[1] Montefiore Medical Center/Albert Einstein Cancer Center,Department of Oncology
[2] Our Lady of Mercy Comprehensive Cancer Center,undefined
来源：
Medical Oncology | 1999年 / 16卷
关键词：
chronic lymphocytic leukemia; theophylline; apoptosis; methylxanthine; cyclic adenosine monophosphate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Theophylline, a methylxanthine commonly used as a treatment for asthma, has been shown to induce apoptosis in chronic lymphocytic leukemia (CLL) cells bothin vitro andin vivo. We have treated three advanced CLL patients with theophylline, and seen responses in two. The clinical courses of the responders are presented, and the literature concerning theophylline as therapy for CLL is reviewed.
引用
收藏
页码：69 / 71
页数：2
相关论文
共 50 条
  • [31] Concurrent hairy cell leukemia and chronic lymphocytic leukemia: Diagnostic and therapeutic implications
    Anoop, Parameswaran
    Patil, Channappa N.
    Sandhya, Venkatachalam
    Dhande, Sonal
    Janardan, Kalpana
    Ahlawat, Shivali
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (04) : 624 - 624
  • [32] Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
    Al-Mendalawi, Mahmood Dhahir
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 102 - 102
  • [33] Therapeutic potential of antagonizing BLyS for chronic lymphocytic leukemia.
    Zhou, T
    Liu, WM
    Zhao, LM
    Carter, RH
    Kimberly, RP
    Emanuel, PD
    BLOOD, 2001, 98 (11) : 808A - 808A
  • [34] NF-κB as a therapeutic target in chronic lymphocytic leukemia
    Lopez-Guerra, Monica
    Colomer, Dolors
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (03) : 275 - 288
  • [35] Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
    Janovska, Pavlina
    Verner, Jan
    Kohoutek, Jiri
    Bryjova, Lenka
    Gregorova, Michaela
    Dzimkova, Marta
    Skabrahova, Hana
    Radaszkiewicz, Tomasz
    Ovesna, Petra
    Blanarova, Olga Vondalova
    Nemcova, Tereza
    Hoferova, Zuzana
    Vasickova, Katerina
    Smyckova, Lucie
    Egle, Alexander
    Pavlova, Sarka
    Poppova, Lucie
    Plevova, Karla
    Pospisilova, Sarka
    Bryja, Vitezslav
    BLOOD, 2018, 131 (11) : 1206 - 1218
  • [36] Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
    Khurana, Sharad
    Ahmed, Salman
    Alegria, Victoria R.
    Aulakh, Sonikpreet
    Ailawadhi, Meghna
    Singh, Anshika
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [37] Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
    Hallek, Michael
    Al-Sawaf, Othman
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1679 - 1705
  • [38] Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies
    Kikushige, Yoshikane
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (04) : 146 - 158
  • [39] Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia
    Arrouss, Issam
    Decaudin, Didier
    Choquet, Sylvain
    Azar, Nabih
    Parizot, Christophe
    Zini, Jean M.
    Nemati, Fariba
    Rebollo, Angelita
    PROTEIN AND PEPTIDE LETTERS, 2015, 22 (06): : 539 - 546
  • [40] Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
    Chowdhury, Subir Roy
    Banerji, Versha
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
12345